Article(id=1236360797341938231, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236360790672986545, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1701273600000, acceptedDateStr=2023-11-30, onlineDate=1772700984558, onlineDateStr=2026-03-05, pubDate=1703865600000, pubDateStr=2023-12-30, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1772700984558, onlineIssueDateStr=2026-03-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1772700984558, creator=13701087609, updateTime=1772700984558, updator=13701087609, issue=Issue{id=1236360790672986545, tenantId=1146029695717560320, journalId=1235980733773295621, year='2023', volume='32', issue='24', pageStart='2441', pageEnd='2543', issueExtLink='null', onlineDate='null', pubDate='null', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1772700982968, creator=13701087609, updateTime=1772701059772, updator=13701087609, preIssue=null, nextIssue=null, ext={EN=IssueExt(id=1236361112883622634, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236360790672986545, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1236361112883622635, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236360790672986545, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null}, startPage=2463, endPage=2466, ext={EN=ArticleExt(id=1236360797656511046, articleId=1236360797341938231, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Considerations of pharmaceutical review of therapeutic recombinant protein drugs for subcutaneous injection, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=

In order to enhance patient compliance, subcutaneous injection (SI) is one of the important directions for differentiated development of therapeutic recombinant protein drugs (TRPDs). This has resulted in a significant rise in clinical trial applications and license applications of biologics in recent years. As for SI products, there are some special considerations in the development of formulation, excipient quality control, product quality control and stability studies compared with those of intravenous administration dosage forms, which are due to the inherent properties of TRPDs and the potential impact of high concentration formulation on product quality and stability, as well as the application of special excipients, represented by hyaluronidase. This manuscript presents a summary of the application of TRPDs in SI dosage form since 2020, discusses the special considerations in the review of chemical manufacturing and control (CMC), and the possible challenges that arise in the R&D and manufacturing process of this type of products. The objective is to offer patients new TRPD products that are safe, effective, quality-controlled, and user-friendly through the collaborative efforts of sponsors and the regulatory authority by strengthening technical communication.

, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, authorCompany=null, fund=null, authors=null, authorsList=Wen-bo SAI, Long-chang XU), CN=ArticleExt(id=1236360797899780694, articleId=1236360797341938231, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=皮下注射剂型治疗用重组蛋白类药物的药学专业审评思考, columnId=1236331159400018080, journalTitle=中国新药杂志, columnName=新药注册与审评技术, runingTitle=null, highlight=null, articleAbstract=

为了提高患者依从性,皮下注射剂型是治疗用重组蛋白类药物差异化开发的重要方向之一。近年来,其临床试验申请和上市申请数量显著增加。而皮下注射剂型产品因治疗用重组蛋白类药物本身的固有属性、高浓度制剂对产品质量和稳定性的潜在影响、以透明质酸酶为代表的特殊辅料的应用等因素,在制剂处方开发、辅料质量控制、制剂质量控制和稳定性研究等方面与静脉给药剂型的药学研究相比存在一些特殊考量。本文汇总了2020年以来皮下注射剂型治疗用重组蛋白类药物申报情况,对药学专业审评中的特殊考量展开讨论,并提出该类药物研发与生产过程中可能存在的挑战,以期通过研发生产机构和监管机构共同努力,强化技术交流,为患者提供安全有效、质量可控、使用便捷的新型治疗用重组蛋白类药物。

, correspAuthors=null, authorNote=null, correspAuthorsNote=
徐隆昌,男,副研究员,主要从事生物制品药学审评工作。联系电话:(010)80996146,E-mail:
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=5iJ/CXXF5++6cw2R1vPgBA==, magXml=A9lzGh2PgMwbqCQoZkwpXA==, pdfUrl=null, pdf=vRNIRR6pPjZLonv7pO7EJg==, pdfFileSize=1078893, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=3RXAzHz2HZtpyzvx8LkGpA==, mapNumber=null, authorCompany=null, fund=null, authors=

赛文博,男,副主任药师,主要从事生物制品药学审评工作。联系电话:(010)80996158,E-mail:

, authorsList=赛文博, 徐隆昌)}, authors=[Author(id=1236360798193381995, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=saiwb@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236360798294045300, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, authorId=1236360798193381995, language=EN, stringName=Wen-bo SAI, firstName=Wen-bo, middleName=null, lastName=SAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236360798411485817, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, authorId=1236360798193381995, language=CN, stringName=赛文博, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio={"content":"

赛文博,男,副主任药师,主要从事生物制品药学审评工作。联系电话:(010)80996158,E-mail:

"}, bioImg=null, bioContent=

赛文博,男,副主任药师,主要从事生物制品药学审评工作。联系电话:(010)80996158,E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236360798084330082, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, xref=null, ext=[AuthorCompanyExt(id=1236360798092718690, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, companyId=1236360798084330082, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China), AuthorCompanyExt(id=1236360798096912995, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, companyId=1236360798084330082, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])]), Author(id=1236360798470206077, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xulc@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236360798566675079, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, authorId=1236360798470206077, language=EN, stringName=Long-chang XU, firstName=Long-chang, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236360798646366859, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, authorId=1236360798470206077, language=CN, stringName=徐隆昌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100076, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236360798084330082, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, xref=null, ext=[AuthorCompanyExt(id=1236360798092718690, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, companyId=1236360798084330082, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China), AuthorCompanyExt(id=1236360798096912995, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, companyId=1236360798084330082, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])])], keywords=[Keyword(id=1236360798755418773, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, language=EN, orderNo=1, keyword=subcutaneous injection), Keyword(id=1236360798860276377, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, language=EN, orderNo=2, keyword=therapeutic recombinant protein drug), Keyword(id=1236360798973522594, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, language=EN, orderNo=3, keyword=formulation), Keyword(id=1236360799044825768, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, language=EN, orderNo=4, keyword=hyaluronidase), Keyword(id=1236360799124517547, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, language=CN, orderNo=1, keyword=皮下注射), Keyword(id=1236360799225180848, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, language=CN, orderNo=2, keyword=治疗用重组蛋白类药物), Keyword(id=1236360799317455543, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, language=CN, orderNo=3, keyword=制剂处方), Keyword(id=1236360799380370108, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, language=CN, orderNo=4, keyword=透明质酸酶)], refs=null, funds=null, companyList=[AuthorCompany(id=1236360798084330082, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, xref=null, ext=[AuthorCompanyExt(id=1236360798092718690, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, companyId=1236360798084330082, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China), AuthorCompanyExt(id=1236360798096912995, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236360797341938231, companyId=1236360798084330082, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100076)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1772610649152, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=C, firstLetterEn=C, subjectCode=Life Sciences, subjectName=null, subjectCodeEn=Life Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1235981903275290962, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649174, updatedTime=1772610649174, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1235981903338205523, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649189, updatedTime=1772610649189, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=C, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2023/V32/I24/2463, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2023/V32/I24/2463, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2023/V32/I24/2463, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2023/V32/I24/2463, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, reference=null)
收藏切换
皮下注射剂型治疗用重组蛋白类药物的药学专业审评思考
收藏切换
PDF下载
赛文博 , 徐隆昌
中国新药杂志 | 新药注册与审评技术 2023,32(24): 2463-2466
收起
收藏切换
中国新药杂志 | 新药注册与审评技术 2023, 32(24): 2463-2466
皮下注射剂型治疗用重组蛋白类药物的药学专业审评思考
全屏
赛文博 , 徐隆昌
作者信息
  • 国家药品监督管理局药品审评中心,北京 100076
  • 赛文博,男,副主任药师,主要从事生物制品药学审评工作。联系电话:(010)80996158,E-mail:

通讯作者:

徐隆昌,男,副研究员,主要从事生物制品药学审评工作。联系电话:(010)80996146,E-mail:
Considerations of pharmaceutical review of therapeutic recombinant protein drugs for subcutaneous injection
Wen-bo SAI , Long-chang XU
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China
出版时间: 2023-12-30
文章导航
收藏切换

为了提高患者依从性,皮下注射剂型是治疗用重组蛋白类药物差异化开发的重要方向之一。近年来,其临床试验申请和上市申请数量显著增加。而皮下注射剂型产品因治疗用重组蛋白类药物本身的固有属性、高浓度制剂对产品质量和稳定性的潜在影响、以透明质酸酶为代表的特殊辅料的应用等因素,在制剂处方开发、辅料质量控制、制剂质量控制和稳定性研究等方面与静脉给药剂型的药学研究相比存在一些特殊考量。本文汇总了2020年以来皮下注射剂型治疗用重组蛋白类药物申报情况,对药学专业审评中的特殊考量展开讨论,并提出该类药物研发与生产过程中可能存在的挑战,以期通过研发生产机构和监管机构共同努力,强化技术交流,为患者提供安全有效、质量可控、使用便捷的新型治疗用重组蛋白类药物。

皮下注射  /  治疗用重组蛋白类药物  /  制剂处方  /  透明质酸酶

In order to enhance patient compliance, subcutaneous injection (SI) is one of the important directions for differentiated development of therapeutic recombinant protein drugs (TRPDs). This has resulted in a significant rise in clinical trial applications and license applications of biologics in recent years. As for SI products, there are some special considerations in the development of formulation, excipient quality control, product quality control and stability studies compared with those of intravenous administration dosage forms, which are due to the inherent properties of TRPDs and the potential impact of high concentration formulation on product quality and stability, as well as the application of special excipients, represented by hyaluronidase. This manuscript presents a summary of the application of TRPDs in SI dosage form since 2020, discusses the special considerations in the review of chemical manufacturing and control (CMC), and the possible challenges that arise in the R&D and manufacturing process of this type of products. The objective is to offer patients new TRPD products that are safe, effective, quality-controlled, and user-friendly through the collaborative efforts of sponsors and the regulatory authority by strengthening technical communication.

subcutaneous injection  /  therapeutic recombinant protein drug  /  formulation  /  hyaluronidase
赛文博, 徐隆昌. 皮下注射剂型治疗用重组蛋白类药物的药学专业审评思考. 中国新药杂志, 2023 , 32 (24) : 2463 -2466 .
Wen-bo SAI, Long-chang XU. Considerations of pharmaceutical review of therapeutic recombinant protein drugs for subcutaneous injection[J]. Chinese Journal of New Drugs, 2023 , 32 (24) : 2463 -2466 .
2023年第32卷第24期
PDF下载
31
9
引用本文
BibTeX
文章信息
  • 首发时间:2026-03-05
  • 出版时间:2023-12-30
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2023-11-30
基金
作者信息
    国家药品监督管理局药品审评中心,北京 100076

通讯作者:

徐隆昌,男,副研究员,主要从事生物制品药学审评工作。联系电话:(010)80996146,E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1236360797341938231
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏